HT
OCUL icon

HAP Trading’s Ocular Therapeutix OCUL Stock Holding History

HAP Trading’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,900
Closed -$31K – 1766
2022
Q3 		$31K Buy
+25,900
New +$130K ﹤0.01% 1102
2021
Q3 		– Sell
-11,000
Closed -$19K – 2658
2021
Q2 		$19K Buy
+11,000
New +$167K ﹤0.01% 1821
2020
Q2 		– Sell
-10,700
Closed -$7K – 1847
2020
Q1 		$7K Buy
+10,700
New +$52.8K ﹤0.01% 1062
2017
Q2 		– Sell
-11,000
Closed -$14K – 1109
2017
Q1 		$14K Buy
11,000
+700
+7% +$5.83K ﹤0.01% 877
2016
Q4 		$15K Buy
+10,300
New +$79.9K ﹤0.01% 800

Other funds holding OCUL

SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HAP Trading's OCUL Position: Q1 2021 in Review

HAP Trading sold out of Ocular Therapeutix (OCUL) in Q1 2021, closing a stake of 63,034 shares — an estimated $1.3M sold.

HAP Trading first reported a position in OCUL in Q4 2020 and held it in 1 quarter. The position peaked at $1.3M in Q4 2020. 154 funds tracked by Wall St. Rank hold OCUL as of Q1 2021.

  • HAP Trading reported no remaining Ocular Therapeutix position as of Q1 2021 after selling out during the quarter.
  • HAP Trading sold 63,034 Ocular Therapeutix shares in Q1 2021, an estimated $1.3M.
  • HAP Trading first reported a position in Ocular Therapeutix in Q4 2020 and held it in 1 quarter.
  • HAP Trading's Ocular Therapeutix position peaked at $1.3M in Q4 2020.
  • 154 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2021.

Based on HAP Trading's 13F filing for Q1 2021, filed 14 May 2021.